On May 5, EBAA alerted the membership about a critical supply issue with the BioRad HIV 1/2 Plus O EIA Assay through an All Member post in The Lens. Two […]
The Policy and Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board has reassessed what is currently known about the risk of transmission of Human T-lymphotropic virus (HTLV) via […]
EBAA Regulatory Alert: FDA Releases Important Information for HCT/P Establishments Regarding Monkeypox Virus and HCT/P Donation August 29, 2022 FDA released a new safety communication for human cells, tissues, or cellular or […]